Request Sample

Global Cancer Biomarkers Market

March 16, 2018

Global Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, and Others), By Application (Prognostics, Research and Development, Risk Assessment, and Disease Diagnosis), By Profiling Technology (Immunoassay, Imaging Technology, Cytogenetics, OMICS Technology, and Others), By End Users (Hospitals, Clinics, Academic and Cancer Research Institutes, Diagnostic Laboratories, and Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Global Forecast, 2020-2025.

Report Code :FMR218      
Industry : Biotechnology
Pages :278 Pages
Format :   PPT Format   PDF Format

The global cancer biomarkers market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020−2025). Cancer biomarkers are biomolecules produced either by the tumor cells or by other cells of the body in reaction to the tumor. Biomarkers can be genes, gene products, specific cells, molecules, enzymes, or hormones which can be perceived in blood, urine, tissues, or other body fluid.

New product launches for cancer biomarkers is projected to boost growth of the market. For instance, in May 2019, Roche launched a new assay that can detect the Human Epidermal Growth Factor Receptor 2 (HER2) biomarker in breast and gastric cancer in the U.K. HER2 is an important biomarker found in breast and gastric cancers. This assay allows faster cancer detection.

 Table 1. Global cancer biomarkers market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Type)

Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, and Others

Market Segmentation (By Cancer Type)

Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, and Others

Market Segmentation (By Application)

Prognostics, Research and Development, Risk Assessment, and Disease Diagnosis

Market Segmentation (By Profiling Technology)

Immunoassay, Imaging Technology, Cytogenetics, OMICS Technology, and Others

Market Segmentation (By End Users)

Hospitals, Clinics, Academic and Cancer Research Institutes

Diagnostic Laboratories, and Ambulatory Surgical Centers

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Abbott Laboratories Inc., Agilent Technologies, 23andMe, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., bioMérieux, Inc., Creative Diagnostics, Illumina Inc., and Thermo Fisher Scientific among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Rise in partnerships among the key players to obtain faster drug results is estimated to lift global cancer biomarkers market over the forecast period. For instance, in November 2018, Biocartis Group signed an agreement with AstraZeneca to receive faster lung cancer molecular diagnostic biomarker results in Europe. Under the agreement, both the companies collaborated to conduct prospective lung cancer study with Biocartis’s Idylla EGFR Mutation Test (CE-IVD) in more than 12 countries in Europe such as in Belgium, France, Germany and Italy.

However, product recalls by key players due to failure in working is projected to hinder the growth of global cancer biomarkers market during the forecast period. For instance, in October 2018, Ventana Medical Systems recalled FLO-LOK III Dispenser Detection kits due to leaking and sticking of reagent dispensers which could cause false negative results. FLO-LOK III Dispenser is used to indicate a disease state through the detection of biomarkers.

Figure 1. cancer biomarker Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Based on the regional segmentation, North America is expected to hold a major share in the global cancer biomarkers market due to increased prevalence of cancer in the U.S. According to National Cancer Institute Statistics 2018, about 1,735,350 cases of cancer were diagnosed in the U.S. and 609,640 people died from the disease.

Figure 2. Regional Analysis

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global cancer biomarkers market include: Abbott Laboratories Inc., Agilent Technologies, 23andMe, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., bioMérieux, Inc., Creative Diagnostics, Illumina Inc., and Thermo Fisher Scientific among others.

Rise in reimbursement programs by government or key players is probable to enhance the market growth. For instance, in July 2018, German Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to evaluate the benefits and potential harm resulting from the use of biomarker-based tests to help doctors decide whether patients with primary breast cancer should receive adjuvant chemotherapy after surgery. Once feedbacks received, company is proposed to provide reimbursements for the biomarker products

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Type

  • Genetic Biomarkers
  • Protein Biomarkers
  • Epigenetic Biomarkers
  • Metabolic Biomarkers
  • Others

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Others

By Application

  • Prognostics
  • Research and Development
  • Risk Assessment
  • Disease Diagnosis

By Profiling Technology

  • Immunoassay
  • Imaging Technology
  • Cytogenetics
  • OMICS Technology
  • Others

By End Users

  • Hospitals
  • Academic and Cancer Research Institutes
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides an in-depth analysis of the global cancer biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global cancer biomarkers market?
  • What key factors are expected to increase the demand for global cancer biomarkers market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global cancer biomarkers market?
  • Which type (genetic biomarkers, protein biomarkers, epigenetic biomarkers, metabolic biomarkers, and others) is expected to dominate the global cancer biomarkers market in the coming years?
  • Which application (prognostics, research and development, risk assessment, and disease diagnosis) is expected to propel the market in the foreseen future?
  • Which profiling technology (immunoassay, imaging technology, cytogenetics, OMICS technology, and others) is expected to propel the market in the forecasted future?
  • What is the total market value (US$ Mn) generated in the global cancer biomarkers market by cancer type in 2019, and what are the forecasts by 2025?
  • What was the total revenue generated by the global cancer biomarkers market across different regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global cancer biomarkers market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the global cancer biomarkers market?
  • What are the new products which are going to be approved or launched in the upcoming years, which may have a huge impact on the market?
  • What insights are derived through the analysis of key players on the following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Recombinant DNA Technology Market

Global Recombinant DNA Technology Market, By Product Type (Recombinant Protein Drugs (Insulin, Human Growth Hormone, Erythropoietin, Interferon, Blood Factors, …

Read More

Global Inactivated Vaccine Market

Global Inactivated Vaccine Market, By Product Type (Viral, Bacterial), By Inactivation method (Radiation Method, pH Concentration, Heat Inactivation, Solvent …

Read More

Middle East and Africa Epigenetics Market

Middle East and Africa Epigenetics Market, By Product type (Consumables, Enzymes, Kits & Reagents, and Instruments), By Application (Oncology, …

Read More

Global Tissue Plasminogen Activator (TPA) Market

Global Tissue Plasminogen Activator (TPA) Market, By Dosage (2mg, 50mg, and 100mg), By Administration Route (Intravenous and Regional Intra-Arterial), …

Read More

Global Biobanks Market

Global Biobanks Market, By Biological samples (DNA or RNA, Plasma, Tissue samples, Stem cells, Amniotic fluid, Cerebrospinal fluid, Blood, …

Read More

Global Vector Control Market

Global Vector Control Market, By Product Type (Insects, Rodents, and Others), Methods of control (Chemical Methods (Pyrethroids (Permethrin, Deltamethrin, …

Read More

Global Medical Drone Market

Global Medical Drone Market, By Type (Fixed Wing, Rotary Drone, and Hybrid Drones), By Application (Search and Rescue (Disaster, …

Read More

Global Agricultural Biotechnological Market

Global Agricultural Biotechnological Market, By Product Type (Plants (Conventional Techniques, Established Genetic Modification, New Breeding Techniques), Animals (Conventional Techniques, …

Read More
Validation error occured. Please enter the fields and submit it again.